Health TrialsbyHealthPanel

Effect of Betadine Vaginal Cleansing Before Cesarean Section to Reduce Postoperative Infectious Morbidity

ConditionsCesarean SectionSurgical Site InfectionEndometritis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
AgeNot listed
SponsorMohamed Mousa Mohamed Mousa

About this trial

This randomized controlled trial aims to evaluate the efficacy of preoperative vaginal cleansing with 5% povidone-iodine in reducing postoperative infectious morbidity among women undergoing cesarean section. The primary outcomes include wound-related complications, while secondary outcomes include postoperative fever, endometritis, wound infection, and white blood cell count.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

Active infection No prophylactic antibiotics Chorioamnionitis Placenta previa with antepartum hemorrhage

Trial design

Design model

Parallel

Treatments tested in this trial

  • Povidone-iodine 5% solution

    Drug

    Vaginal cleansing with 5% povidone-iodine for 30 seconds before cesarean section.

Treatment groups

600 Participants
are divided into 2 treatment groups
Group A: Betadine Vaginal CleansingExperimental treatment 1 intervention
Group B: No Vaginal CleansingNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Incidence of postoperative wound-related complications Time Frame: Within 8 weeks after cesarean section

Time frame
8 weeks
2

Incidence of postoperative wound-related complications

Time frame
Within 8 weeks after cesarean section

Secondary outcomes

1

Postoperative fever (within 8 weeks) Postoperative WBC count (24 hours) Endometritis (within 8 weeks) Combined wound complications and endometritis

Time frame
8 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Mohamed Mousa Mohamed Mousa

Lead sponsor

Al-Azhar University

Sponsor institution

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: